Skip to main content
. 2022 Dec 29;27(6):1026–1036. doi: 10.5603/RPOR.a2022.0113

Figure 3.

Figure 3

Survival analysis with adjuvant temozolomide (TMZ) vs. no adjuvant temozolomide